Melorem (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which is essential for the production of prostaglandins that cause inflammation, pain, and fever. By lowering prostaglandin levels at sites of inflammation, the drug provides anti‑inflammatory and analgesic effects while sparing COX‑1 activity that protects the stomach lining.

The appropriate dose of Melorem is determined by the prescribing healthcare professional based on the patient’s condition, severity, and individual response. Dosage adjustments may be required for renal or hepatic impairment, and the prescriber will provide specific instructions.

Safety of meloxicam in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam offers a relatively selective COX‑2 inhibition, which may result in a lower incidence of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or naproxen. However, cardiovascular and renal safety considerations remain similar across the class, and choice of therapy should be individualized.

Melorem should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Melorem is taken orally, usually with a full glass of water. It may be taken with or without food, but if gastrointestinal upset occurs, taking it with meals can help minimise discomfort.

Serious risks include gastrointestinal ulceration or bleeding, severe liver injury, acute kidney failure, and an increased chance of cardiovascular events such as heart attack or stroke, especially with long‑term use or in patients with existing cardiovascular disease.

Melorem is contraindicated in patients with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulceration, and individuals with severe heart failure or uncontrolled hypertension. Patients with significant renal or hepatic impairment should also avoid use unless specifically directed by a physician.